Integrative Medicine on the treatment of children with chronic diarrhea of 40 Cases.docVIP

 PAGE \* MERGEFORMAT 8 Integrative Medicine on the treatment of children with chronic diarrhea of 40 Cases [Abstract] Objective To observe Qiweibaizhu Powder and zinc combination therapy efficacy in children with chronic diarrhea. Methods 80 cases of children with chronic diarrhea were randomly divided into treatment group of 40 patients and a control group of 40 patients. The basis of the control group treated with conventional Western medicine and zinc supplementation, the treatment group were treated on the basis of additional services Qiweibaizhu Powder, 2 weeks of treatment were calculated after continuous treatment. Results The clinical cure rate was 75.0%, total effective rate was 95.0%; control group, the clinical cure rate was 60.0%, total effective rate was 77.5%. Conclusion Qiweibaizhu Powder and zinc combination therapy in children with chronic diarrhea can improve efficacy, reduce course, is worthy of clinical use. [Keywords:] Qiweibaizhu Powder; zinc; children with chronic diarrhea Diarrhoeal diseases are caused by many factors of digestive tract diseases (1). According to the course is divided into acute diarrhea (≤ 2 weeks), persistent diarrhea (≤ 2 months), chronic diarrhea (gt; February). Children with chronic diarrhea ( chronic diarrhea disease CDD) causes of complex common clinical and refractory, more performance for the increased frequency of bowel movements, thin stool water or egg patterns, clip mucus, foam, or indigestion of food, accompanied by malnutrition, abdominal distension, abdominal pain , lack of energy, irritability embolism, cause severe digestive disorders, severe malnutrition. the author in January 2005 to December 2008, the use of Integrative Medicine 40 cases of children with chronic diarrhea, good effect, are as follows. 1 Clinical data 1.1 General Information All patients in our hospital system and outpatient department patients were randomly divided into treatment group and control group. 40 patients